DUTCH Test Review: What $499 Actually Buys — and What It Won’t
Before you spend $499 on a hormone panel
Separate a real diagnosis, treatment, or risk question from a broad panel that may leave you with more numbers but no clinician-led plan.
Our DUTCH test review verdict: DUTCH Complete costs $499. Published studies support selected dried-urine measurements and the four-spot collection method, but they do not show that buying the commercial panel improves routine perimenopause diagnosis or HRT decisions. For most women seeking a menopause answer, this is not the best first $499.
Best for: someone whose clinician already uses DUTCH, has defined the exact question before ordering, and will interpret the report and explain what would change under each possible result.
Probably not for you if: you want to diagnose perimenopause, decide whether to start HRT, prove that your symptoms are real, adjust compounded-hormone doses from urine numbers, or buy first and find an interpreter later.
| Decision fact | Verified answer |
|---|---|
| Direct price | $499 for DUTCH Complete |
| Interpretation included | No. Precision Analytical says a healthcare provider is needed to interpret results and build a treatment plan |
| What the research supports | Selected measurement agreement and collection-method reliability under the conditions studied |
| What the research does not establish | That the full commercial panel improves routine menopause diagnosis, prescribing decisions, symptoms, or health outcomes |
| Insurance | Precision Analytical does not bill or accept insurance and considers itself out of network; provider-ordered testing may be submitted for possible reimbursement |
| State restriction notice | Restrictions apply in New York, Maryland, and Rhode Island; the lab tells residents to call before ordering |
| Return terms | One year if the kit is returned; shipping is non-refundable and a $25 restocking fee applies |
That is the verdict. Now here is the part almost nobody tells you, and it is the reason this page exists.
The $499 is not the price. It is the entry fee. A direct purchase does not include clinical interpretation. Precision Analytical’s own FAQ says anyone can purchase a test, but a healthcare provider is needed to interpret the result and build a treatment plan. The sample report currently linked from the DUTCH Complete store page is 13 pages. A report that nobody will use is not an answer; it is a new problem.
You do not actually want a test. You want someone to take you seriously.
Those are two different purchases. Only one of them costs $499.
Who we are, and why we spent a week on a product we do not sell
The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.
We earn commissions from some telehealth providers named near the end of this page. Every compensated link is labelled where it appears. We earn nothing from DUTCH. The test we do not make money from gets the most space here, because it is the thing you came to decide.
We also want to be straight about our limits up front: we did not buy a kit or send in a sample for this review. This is a documentation review. Every commercial number comes from a page we opened and dated, and every medical or regulatory conclusion is tied to a primary source or peer-reviewed paper. We show what we checked—and what remains unresolved—in section 18.
One thing before you keep reading
The right online HRT provider is not the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer cannot resolve those for you, use The HRT Index’s Find My HRT Path tool to match your situation to the right provider — and to flag when online care is not the right starting point — before your first consult.
1. DUTCH test review verdict: is it worth $499?
For most women trying to work out whether they are in perimenopause or whether to start hormone therapy, no. DUTCH can be a rational specialty test when a clinician has already defined a narrow question and can explain how each possible result would change care. That is a much tighter use than “find out what is wrong with my hormones.”
This search is full of people yelling past one another.
One group sells DUTCH as an unusually comprehensive hormone panel. Another calls the entire thing meaningless. Both sides skip the decision you are actually making: not “can a laboratory produce numbers?” but “will these numbers change what happens next?”
There are three separate questions hiding inside “is the DUTCH test accurate?”
- Can the method measure selected analytes consistently? That is analytical performance.
- Does a result reliably identify a clinically defined condition in a patient like you? That is clinical validity.
- Does using the result improve a decision or outcome? That is clinical utility.
A test can do well on the first question and still leave the third unanswered. That is not a scandal. It is the distinction that decides whether the test is worth your money.
What the published evidence does—and does not—prove
| Evidence question | What was studied | What it supports | What it does not prove |
|---|---|---|---|
| Can dried urine resemble liquid urine for selected markers? | The 2019 method paper compared dried and liquid urine for selected estrogen and progesterone metabolites | Dried filter-paper collection can produce measurements comparable with liquid urine for the analytes and conditions studied | That the full commercial DUTCH Complete panel diagnoses perimenopause or improves treatment |
| Can four timed spots approximate a 24-hour collection? | The 2021 paper compared a four-spot method with a 24-hour collection in 26 people; dried-versus-liquid comparisons used 18 people | The four-spot approach can approximate 24-hour excretion for many measured hormones and metabolites in that sample | That one collection day captures every clinically relevant fluctuation, or that a laboratory range creates a diagnosis |
| Do urine values track exposure after transdermal estradiol? | Route-specific papers studied estradiol gel and patch exposure | Urinary metabolites can reflect transdermal exposure under the protocols studied | A validated dosing algorithm, symptom benefit, or improved safety from ordering the commercial panel |
| Does DUTCH improve routine menopause care? | We found no randomized or comparative trial of DUTCH-guided versus guideline-based menopause care | A clear evidence gap | No published proof that buying the commercial panel improves routine diagnosis, prescribing, symptoms, or outcomes |
The principal 2019 and 2021 method papers were funded by Precision Analytical. Company-affiliated authors disclosed their roles; the studies also included outside academic or statistical involvement. Industry funding does not erase data. It makes endpoint discipline non-negotiable: method agreement is not clinical utility.
The 2021 sample was small and reported all participants as Caucasian. Reference intervals were laboratory-specific. Those facts do not make the measurements false. They limit how far anyone should stretch the results.
Peer-reviewed sources: 2019 BMC Chemistry method paper and 2021 BMC Chemistry reliability paper.
When the purchase can make sense
We would consider the $499 rational when all of these are true:
- A clinician who already uses DUTCH has named the exact question.
- That clinician can say what would change if the result is high, low, or inside the laboratory range.
- The question is narrower than “Do I have perimenopause?” or “Should I start HRT?”
- Interpretation and follow-up are arranged before the kit is used.
- The clinician has addressed whether your medication route makes urinary interpretation suitable.
- A less expensive targeted test cannot answer the same question.
A specialist may use a timed cortisol pattern, a transdermal-exposure question, or a research-oriented metabolite question as one part of a wider evaluation. That is a defensible use case. It is not evidence that every symptomatic woman needs the flagship panel.
There is a clinician in every good version of this purchase, and she has a question before you have a result.
2. What is the DUTCH test, and what does it measure?
DUTCH stands for Dried Urine Test for Comprehensive Hormones. Precision Analytical, founded in 2012 in McMinnville, Oregon, sells several urine and saliva panels; its $499 flagship reports 35 hormones and metabolites, a daily cortisol pattern, melatonin and oxidative-stress markers, plus six organic-acid markers.
A metabolite is a substance produced as your body processes another substance. DUTCH does not simply reproduce a conventional blood panel on paper. Much of its value proposition is that urine can show hormone metabolites and estimated daily output rather than one circulating concentration at one moment.
What is in DUTCH Complete
According to the current product page, the report includes:
- Estrogens: estradiol, estrone, estriol, and selected downstream estrogen metabolites.
- Progesterone: represented mainly through urinary progesterone metabolites.
- Androgens: testosterone, DHEA-S, and androgen metabolites.
- Cortisol and cortisone: free measurements across the day plus metabolized cortisol and cortisone.
- Melatonin: reported through 6-OHMS.
- 8-OHdG: an oxidative-stress marker reported by the laboratory.
- Six organic-acid markers: methylmalonate, xanthurenate, kynurenate, pyroglutamate, homovanillate, and vanilmandelate.
The laboratory uses mass-spectrometry methods, including GC–MS/MS and LC–MS/MS. That is real laboratory instrumentation—not a home color strip. Precise instrumentation still does not answer whether ordering the panel improves your care.
Manufacturer source: DUTCH Complete product page, verified September 3, 2026.
What collecting it actually involves
DUTCH Complete uses four standard timed urine samples, with a fifth mid-sleep sample if you wake to urinate:
- around dinnertime;
- at bedtime;
- on waking;
- two hours after waking;
- and an additional overnight sample when the current instructions call for one.
The instructions also include food, medication, supplement, exercise, sleep, and fluid rules. Follow the instructions that arrive with your kit rather than a review page, because preparation requirements vary by panel and can change. Current DUTCH Complete materials tell users not to drink fluids for two hours before each sample and to keep total fluids at or below 40 ounces on the collection day.
Cycle Mapping is a different burden. It uses repeated collections across the menstrual cycle. Cycle Mapping Plus currently includes 25 urine strips and six saliva tubes. The manufacturer says Cycle Mapping is not intended for women using hormonal birth control.
That collection burden belongs in the buying decision. You are not paying only with money. You are paying with a controlled collection day—or most of a cycle—and a result whose usefulness depends on what happens after it arrives.
3. Who is the DUTCH test actually designed for?
Precision Analytical now supports two paths at once: a provider-led patient pathway and a direct online store. Its FAQ says anyone can purchase, but also says a healthcare provider is required to interpret the result and build a treatment plan. Our conclusion is that the report remains designed around a practitioner relationship, even when the kit is bought directly.
The company’s patient pathway tells people to ask their current provider, find a DUTCH provider if needed, and have the provider order the test after consultation. The store, meanwhile, offers all eight panels with an add-to-cart button.
| Where you enter | What the company tells you | What it means before you pay |
|---|---|---|
| Main patient pathway | Find or ask a DUTCH provider; testing follows consultation | Interpretation is part of the intended workflow |
| DUTCH FAQ | Anyone may purchase, but a provider is needed to interpret and build a plan | Direct purchase does not remove the interpretation problem |
| Direct storefront | Choose a panel and add it to cart | The kit can be bought before the clinical question is settled |
This is not an accusation. It is the most useful commercial fact on the entire site.
DUTCH’s practical customer relationship is practitioner-centered. That helps explain why the public review pool is tiny, why the company’s educational ecosystem is provider-heavy, and why a self-order can leave you holding a technically detailed report without a clinician willing to use it.
Before buying, ask the person who will receive the report:
“Do you use DUTCH results in treatment decisions, and what exactly would you do differently under each possible result?”
If the answer is vague, the test will not make it less vague.
Manufacturer sources: DUTCH patient pathway and DUTCH FAQ, verified September 3, 2026.
4. How much does the DUTCH test cost in 2026?
Precision Analytical’s direct prices currently run from $299 to $700. DUTCH Complete is $499; DUTCH Plus is $650; Cycle Mapping is $550; the Cycle Mapping + Complete bundle is $650; and Cycle Mapping Plus is $700. Resellers can charge a different price for a panel processed by the same lab.
Most reviews round this to “about $500” and move on. Here is the complete direct price list.
Every direct DUTCH panel price
Source: Precision Analytical’s own storefront. Verified September 3, 2026.
| Panel | Direct price | Collection format | What the panel adds or removes |
|---|---|---|---|
| DUTCH Complete | $499 | Four standard timed urine samples; a fifth mid-sleep sample if you wake to urinate | 35 hormones and metabolites, daily cortisol pattern, melatonin, 8-OHdG, and six organic-acid markers |
| DUTCH Plus | $650 | Four urine strips + six saliva tubes | DUTCH Complete plus the cortisol awakening response |
| DUTCH Cycle Mapping | $550 | Repeated dried-urine samples across a menstrual cycle | Nine targeted estrogen and progesterone measurements across the cycle; female-only |
| Cycle Mapping + Complete bundle | $650 | Cycle Mapping plus a DUTCH Complete collection | Both panels without the added saliva-based awakening response |
| DUTCH Cycle Mapping Plus | $700 | 25 urine strips + six saliva tubes | Cycle Mapping, DUTCH Complete, and cortisol awakening response; female-only |
| DUTCH Adrenal | $399 | Dried urine | Free cortisol/cortisone pattern, metabolized cortisol/cortisone, and DHEA-S; no full sex-hormone panel |
| DUTCH Sex Hormone Metabolites | $399 | Dried urine | Sex hormones and selected metabolites without the full adrenal and organic-acid components |
| Cortisol Awakening Response | $299 | Six saliva tubes | Five cortisol and five cortisone measurements around waking |
The bundle math nobody points out
Cycle Mapping alone is $550. Cycle Mapping plus the full Complete panel is $650. Inside that bundle, the second panel adds $100.
Cycle Mapping Plus is $700—another $50—and adds the cortisol awakening response, which is $299 when purchased as a standalone panel.
That does not mean the biggest bundle is automatically the smartest buy. It means the store’s price ladder punishes adding a panel later:
- Cycle Mapping now: $550
- DUTCH Complete later: $499
- Combined spend: $1,049
- Current Cycle Mapping + Complete bundle: $650
- Difference: $399
The price ladder rewards deciding everything before you click. The clinical decision should work the other way: define the question first, then buy only the panel that can answer it.
The same laboratory panel can have two prices
We also checked the independent consumer reseller DUTCHTestHormones.com. Its own footer says it is not affiliated with or endorsed by Precision Analytical and that licensed practitioners authorize its orders. These are posted prices, not a quality comparison.
| Panel | Precision Analytical store | Reseller | Difference |
|---|---|---|---|
| DUTCH Complete | $499 | $499 | Same |
| DUTCH Cycle Mapping | $550 | $549 | Reseller $1 less |
| DUTCH Plus | $650 | $675 | Reseller $25 more |
| DUTCH Cycle Mapping Plus | $700 | $799 | Reseller $99 more |
| DUTCH Adrenal | $399 | $399 | Same |
| Sex Hormone Metabolites | $399 standalone | $289 add-on | Not like-for-like |
| Cortisol Awakening Response | $299 standalone | $199 add-on | Not like-for-like |
The reseller also warns of processing waits of up to four weeks. Its extra price may reflect a different ordering and support path; the page does not provide a line-by-line value breakdown that explains the full difference.
Same Precision Analytical panel. Different checkout, different service path, different price. Before paying a reseller, open the laboratory store in another tab and compare the exact panel, interpretation, shipping, and support terms.
Reseller source: DUTCHTestHormones.com, checked September 3, 2026.
Before you compare panels, decide whether hormone testing belongs in your decision at all. Find My HRT Path maps your symptoms, age, uterus status, state, treatment preferences, and payment route to a starting point—and flags when online care is not the right first step. It takes about 90 seconds. →
5. Is the DUTCH test covered by insurance? What about HSA or FSA?
Precision Analytical does not bill or accept insurance and considers itself out of network. A provider-ordered test may be submitted for possible out-of-network reimbursement, but the company does not promise payment. That is the accurate answer—not “insurance always covers it,” and not “no insurer ever will.”
That distinction matters because the payer policy most often cited here covers salivary testing. It does not prove a blanket denial for the dried-urine panel.
What the published policies actually prove
| Source | What it says | What it proves | What it does not prove |
|---|---|---|---|
| Precision Analytical FAQ | The lab does not bill or accept insurance; it is out of network; a provider-ordered test may be submitted for possible reimbursement | Your default expectation should be cash pay, with reimbursement uncertain | That every health plan denies every DUTCH panel |
| Aetna Clinical Policy Bulletin 0608 | Aetna treats specified salivary hormone tests—including cortisol when used for menopause or aging claims—as experimental, investigational, or unproven and lists HCPCS S3650, “saliva test, hormone level; during menopause” | Aetna has explicit noncoverage language for the salivary indications and code listed in its policy | That the policy is a direct coverage determination for dried-urine DUTCH Complete, or that it overrides an individual plan document |
| Your own plan documents | Coverage turns on plan language, medical necessity rules, ordering provider, network status, coding, and benefit exclusions | The plan is the only source that can answer your claim | A receipt or billing code guarantees reimbursement |
The presence of a billing code is not proof of coverage. HCPCS S3650 is explicitly a saliva test code. DUTCH Complete is primarily dried urine; DUTCH Plus adds saliva. Treating that code as a universal DUTCH-denial code would be neat, dramatic, and wrong.
Sources: DUTCH FAQ and Aetna Clinical Policy Bulletin 0608, checked September 3, 2026.
The four questions to ask your insurer before buying
Use the exact panel name. Then ask:
- Is testing by Precision Analytical, an out-of-network laboratory, eligible under my plan?
- Does the plan cover the urine and saliva components ordered for my diagnosis—not merely the individual analytes?
- Does the test need prior authorization or an in-network ordering clinician?
- What documentation and claim form would I need, and what amount would count toward my deductible?
Get the answer in writing or save the call reference number. “You can submit a receipt” and “we will reimburse it” are two different sentences.
Can you use an HSA or FSA card?
Precision Analytical says it accepts HSA and FSA payment when the account provides a payment card. That verifies merchant acceptance. It does not decide whether the expense is a qualified medical expense under your plan and current tax rules.
The clean answer is:
- Card acceptance: yes, according to DUTCH.
- Tax qualification or reimbursement: confirm with your plan administrator or tax adviser.
- Economic effect: using pre-tax funds does not reduce the sticker price. It changes which dollars pay it.
Do not turn the HSA/FSA answer into a universal “effective price.” The tax effect depends on the account, plan rules, and the reader’s actual tax situation.
6. What will the DUTCH test really cost you to get an answer?
The verified kit price is $499. The all-in decision cost is not published because interpretation, follow-up, other testing, treatment, shipping outside the stated terms, and repeat collection vary by route. The most expensive version is the $499 report nobody will use.
The direct price buys collection materials, laboratory processing, a graphical report, and the manufacturer’s educational resources. It does not buy a clinician who knows you, accepts responsibility for the decision, and will follow up after the report lands.
The two doors
Door one: your clinician orders or supports the test.
This is the coherent path. You know who is interpreting the report. You can ask what the test is meant to decide, what interpretation costs, and what happens next.
Door two: you buy the test first.
Precision Analytical’s FAQ allows that. The clinical problem remains yours. You still need to find a qualified clinician who will use the report, pay any consultation fee, and decide whether another test or visit is required.
The storefront and the provider-first patient pathway are not mutually exclusive. Together they say something simple: the company will sell you a kit directly, but the company does not say the kit alone is a treatment plan.
What the full path can include
| Purchase route | Verified panel cost | Interpretation | Costs to confirm before purchase |
|---|---|---|---|
| Existing clinician orders it | $299–$700, depending on panel | May be included in an existing visit or billed separately | Visit fee, follow-up, repeat testing, treatment |
| New DUTCH-oriented practitioner | Panel price or practitioner-set bundle | Often separate or bundled; no universal public rate | Consultation, package term, supplements, follow-up, cancellation |
| Direct laboratory storefront | $299–$700 | Not included as an independent clinical consultation | Interpreter, follow-up, shipping/customs where applicable |
| Buy first, ask your usual clinician later | $299–$700 | Unknown until the clinician agrees to review it | Whether the clinician will use it at all |
One 2023 Trustpilot reviewer reported being quoted $300–$400 for a consultation with a DUTCH-oriented clinician. That is one person’s report, not a current published rate. We did not turn it into a universal price.
Precision Analytical reports an average laboratory turnaround of 6–7 days once the specimen is in the lab. Your real wait also includes kit delivery, collection timing, return shipping, report release, and the next available discussion with your clinician.
The return policy, and why it matters more than you think
The current product pages state:
- refunds are available within one year of purchase;
- the kit must be returned before a refund is issued;
- shipping fees are non-refundable;
- a $25 restocking fee applies;
- a credit-card refund may take up to 30 days.
The published language does not promise a refund after a specimen has been processed. Do not discover the interpretation problem after collection. Confirm the return status before using the kit if you are reconsidering.
Three questions to answer before you pay anyone
- Who specifically will read this report with me, and what will that cost?
- What medical decision changes under a high, low, normal, or ambiguous result?
- If the panel does not explain my symptoms, what happens next?
If you cannot answer all three, you are not ready to buy yet. That is not a judgment. It is arithmetic.
If what you actually want is a clinician who takes your symptoms seriously without a $499 entry fee, that is a solvable problem. Find My HRT Path takes about 90 seconds and gives you a best-fit care route, two backups, and a safety flag when online care is not the right starting point. →
7. Can you use DUTCH while taking oral, sublingual, or transdermal HRT?
Medication route changes what urinary metabolites mean. DUTCH’s own 2019 method paper says oral and sublingual hormones undergo first-pass liver metabolism and that “urine evaluation may not be appropriate.” The same paper describes a possible role for some transdermal-estrogen monitoring. Neither statement creates a universal DUTCH dosing algorithm.
This is specific, checkable, and important enough to stand alone.
When you swallow a hormone, it passes through the liver before reaching the wider circulation. Sublingual dosing can also produce route-dependent metabolism and exposure. A patch, gel, or other transdermal product avoids gastrointestinal absorption and much of that first pass.
Urine testing looks at what the body has processed and excreted. Change the route and you change the metabolite picture. The authors of the 2019 paper—including Precision Analytical’s founder—flagged that limitation themselves.
If you take an oral or sublingual hormone and someone proposes DUTCH to “check your levels” or adjust the dose, ask:
“Your 2019 method paper says urine evaluation may not be appropriate for oral or sublingual routes. What exact result are you using, and how has that use been validated for my medication?”
A good clinician should be able to answer without changing the subject.
What the transdermal papers add
Precision Analytical-affiliated researchers later published route-specific studies involving estradiol gel and patches. Those papers add useful pharmacokinetic evidence: urinary estrogen metabolites can track exposure under the studied transdermal protocols.
They do not show that every woman using a patch needs DUTCH, that the commercial report identifies a universally correct dose, or that DUTCH-guided dose changes improve symptoms or safety.
The compounded-hormone line this page will not cross
The Menopause Society states that salivary and urine hormone testing to determine dosing of compounded bioidentical hormone therapy is unreliable and not recommended. Serum testing is also rarely needed for that purpose.
So this page does not recommend buying DUTCH to self-adjust a compounded cream, troche, or pellet. Compounded medications are not FDA-approved, and urine numbers do not turn self-dosing into safe prescribing.
Sources: 2019 route discussion, The Menopause Society 2022 position statement, and the route-specific papers in the source list.
8. Is the DUTCH test FDA approved?
No. DUTCH is not FDA-cleared or FDA-approved. The FDA’s 2024 laboratory-developed-test rule was vacated by a federal court in March 2025, and the agency restored the previous regulatory text in September 2025. That history does not make DUTCH approved, fraudulent, clinically useful, or clinically useless. It means the FDA label needs a precise answer.
Almost every page on this topic uses “not FDA approved” as a full argument. It is not one.
What changed
| Date | What happened | What it means here |
|---|---|---|
| May 6, 2024 | FDA issued a final rule changing its regulation of laboratory-developed tests | The agency planned phased device requirements for many LDTs |
| March 31, 2025 | A federal district court vacated the rule | The 2024 rule did not remain in force |
| September 19, 2025 | FDA issued a rule reverting the affected regulatory text | The public FDA page now describes the vacatur and reversion |
DUTCH is offered as a laboratory-developed testing service performed within Precision Analytical. It has not received FDA premarket clearance or approval as a commercial test kit.
What CLIA does—and does not—tell you
The Centers for Medicare & Medicaid Services regulates clinical laboratories under CLIA. Precision Analytical has a current CLIA Certificate of Compliance. CLIA addresses laboratory operations and quality requirements for testing human specimens.
CLIA certification does not establish that every marketed use of a test has clinical utility. It does not prove that a DUTCH report diagnoses perimenopause, improves HRT selection, or leads to better outcomes.
In DUTCH’s favor: FDA non-approval by itself is not proof that the measurements are false.
Against overclaiming: current CLIA status is not a substitute for evidence that buying the panel changes care.
Primary sources: FDA laboratory-developed-tests page and CMS CLIA overview.
9. What do doctors and medical societies say about DUTCH testing for menopause?
The consistent message is narrower than “all testing is useless”: typical perimenopause and menopause are usually diagnosed clinically, not with a broad hormone panel; urine or saliva testing should not be used to set compounded-hormone doses; and targeted tests still have a role when age, symptoms, bleeding, or another possible condition changes the question.
Here is the guidance without stretching it beyond its scope.
| Source | What it says | The decision it supports |
|---|---|---|
| ACOG patient guidance | Most women do not need hormone testing during perimenopause; age, symptoms, and menstrual changes often provide enough information | Do not buy a $499 panel merely to obtain permission to discuss treatment |
| NICE menopause guideline | In otherwise healthy people aged 45 or older with typical symptoms, identify perimenopause or menopause without laboratory tests | Routine hormone confirmation is usually unnecessary in that group |
| NICE on FSH | Consider FSH in people aged 40–45 with menopause symptoms and cycle change, or under 40 when menopause is suspected; suspected premature ovarian insufficiency requires a more specific workup | Younger or atypical cases are different from routine midlife diagnosis |
| The Menopause Society | Saliva and urine testing to determine compounded-hormone dosing is unreliable and not recommended; serum testing is rarely needed for that purpose | Do not use a commercial panel as a self-directed compounded-dose calculator |
| ACOG Clinical Consensus No. 6, endorsed by ASRM | In the compounded-menopausal-hormone context, adjunctive salivary and urinary hormone tests are not recommended for prescribing or dosing | Separate specialty testing from evidence-based compounded-hormone dosing |
Source: Sources:* ACOG on hormone testing during perimenopause, NICE guideline NG23, The Menopause Society position statement, and ACOG Clinical Consensus No. 6.
Now the part that usually gets left out
If we stopped at “you do not need this panel,” we would be doing exactly what a dismissive appointment may already have done: telling you what you do not need and then walking away.
Not needing a broad hormone panel does not mean nothing is wrong. It does not mean your symptoms are imaginary. It does not mean you are disqualified from treatment.
For a woman over 45 with typical symptoms and cycle changes, the clinical history can be the evidence. The next decision is whether her symptoms, preferences, uterus status, risk history, and treatment goals make hormone therapy, a non-hormonal option, local treatment, further evaluation, or another path the right fit.
That is not “there is nothing wrong with you.”
That is “you do not need a $499 number to earn a serious conversation.”
For the wider treatment decision, see HRT benefits, risks, and who it is right for.
10. What do real DUTCH test reviews say?
There are only five on Trustpilot. The profile showed five total reviews and a 2.8 out of 5 TrustScore when checked on September 3, 2026. That sample cannot support a reliable product rating. It can show the kinds of process failures and successes people bothered to report.
You searched for a DUTCH test review. So we counted the review pool instead of pretending it was larger than it is.
The Trustpilot profile, counted
| Profile fact | What was displayed when checked |
|---|---|
| TrustScore | 2.8 / 5 |
| Total reviews | 5 |
| Rating mix | One 5-star review and four 1-star reviews |
| Profile status | Unclaimed |
| Invitation status | Reviews displayed as unprompted; Trustpilot showed no company invitation activity |
A 2.8 based on five self-selected reviews is not a clinical finding, and it is not a stable consumer rating. One additional review could move it materially. We do not turn that number into a score for the test.
What all five people reported
Every row below is a paraphrase of the public review, not an endorsement of its accuracy. None is used as evidence that the test works—or does not work—medically.
| Reviewer | Posted | Rating | What the review reported |
|---|---|---|---|
| Galynne Davis | June 28, 2025 | 5 stars | Found it helpful; sent the report to her doctor and used it alongside other tests in perimenopause care |
| Sam | March 23, 2026 | 1 star | Said the glossy vial labels were difficult to write on even though collection details had to be recorded |
| Nagina Hosany | October 23, 2025 | 1 star | Reported unexpected customs and return-shipping costs on an international order and confusion about the practitioner pathway |
| Laura B | July 1, 2023 | 1 star | Reported personal-detail errors, a delayed rerun, privacy concerns, and inconsistent-looking reference information |
| Al | May 23, 2023 | 1 star | Reported conflict with serum testing, concern about hydration during collection, an additional interpretation quote, and no refund |
The most useful positive detail is not “five stars.” It is the workflow: the buyer already had a doctor, and the report was one input among several.
That is the person most likely to get value here. It is the opposite of buying a panel because nobody will listen and hoping the PDF will force them to.
What the tiny review pool tells you
Precision Analytical markets DUTCH through a provider network and a patient-facing store. Yet its public Trustpilot profile has five reviews.
That is not proof of a hidden problem. It is consistent with a provider-mediated business: the practitioner chooses the laboratory, and the patient may never think of herself as the laboratory’s customer.
Which is exactly why honest consumer reviews are so hard to find—and why a five-review score should never carry the verdict.
Company-published stories are a different evidence pool
DUTCH also publishes patient and athlete stories on its own website. Those are company-selected marketing assets, not independent reviews. We do not average them with Trustpilot, and we do not use either pool to prove efficacy.
Review source: Trustpilot profile for dutchtest.com, verified September 3, 2026.
11. Is Precision Analytical a legitimate laboratory?
Yes. Precision Analytical holds a current CLIA Certificate of Compliance, CLIA ID 38D2047310, effective February 20, 2025 through February 19, 2027. Current CAP accreditation is not established by the public document linked from the company’s licensing page. Those are two separate findings, and both belong on the page.
This is where copy-and-paste reviews usually fail. They turn laboratory credentials into one undifferentiated badge.
The license-document audit
| Claim | Evidence we found | Publishing status |
|---|---|---|
| Current CLIA certification | CMS Certificate of Compliance, CLIA ID 38D2047310, effective February 20, 2025; expiration February 19, 2027 | Verified |
| Participation in CAP proficiency testing | The licensing page says the lab participates in quality-assurance and proficiency-testing programs, including CAP | Verified as company-stated participation |
| Current CAP accreditation | The page also uses “certified by CAP,” but the linked public PDF is a 2018 CAP Surveys participation certificate | Not established by the public artifact |
| State laboratory licenses | The licensing page links state documents, including California and Maryland | Not independently summarized here; certificate identities, dates, and current status were not verified in this review |
The licensing page itself uses two different formulations: one describes CAP proficiency-program participation; another says “certified by CAP.” The linked 2018 document is titled as participation in CAP Surveys and education programs. It is not current proof of accreditation in CAP’s Laboratory Accreditation Program.
That does not make the lab illegitimate. It means the public evidence supports current CLIA certification and a company-stated claim of CAP proficiency participation, while current CAP accreditation remains unresolved.
What CLIA tells you
CLIA is meaningful. It governs laboratories that test human specimens and covers quality systems, personnel, proficiency testing, and related operational requirements.
CLIA does not decide whether every marketed application of a test improves patient care. A current certificate answers “is this a real regulated clinical laboratory?” It does not answer “should this woman spend $499 for this decision?”
Documents: Precision Analytical licensing page, current CLIA certificate, and 2018 CAP Surveys participation certificate.
12. Can you order the DUTCH test in your state?
Precision Analytical’s direct product pages say restrictions apply in New York, Maryland, and Rhode Island and tell residents to call the laboratory. The pages do not say the test is categorically unavailable in all three states, so this review does not say that either.
| State | What the current product pages say | What to do |
|---|---|---|
| New York | Restrictions apply | Call Precision Analytical before ordering and confirm the permitted route |
| Maryland | Restrictions apply | Call before ordering; do not assume the direct checkout applies to you |
| Rhode Island | Restrictions apply | Call before ordering and confirm current requirements |
| Other U.S. states | No equivalent notice displayed on the checked product pages | Confirm checkout, clinician, and laboratory requirements for your address |
We did not find one public manufacturer page explaining the exact operational restriction for each state. That gap stays visible. “Restrictions apply” is the verified fact; “you cannot order” would be an invention.
International buyers also need to confirm customs, duties, return shipping, specimen stability, and whether a local clinician will interpret the report. One Trustpilot complaint involved unexpected cross-border costs. One complaint does not create a universal policy, but it gives you a useful pre-purchase question.
Manufacturer source: the restriction notice on the DUTCH Complete product page and the other direct panel pages, checked September 3, 2026.
13. What might this DUTCH test review be getting wrong?
The strongest case against our verdict is that broad metabolite and cortisol data can reveal a pattern a skilled specialist finds useful in a complex patient—and no randomized trial can tell you whether that one result will matter to you. That possibility is real. It still does not justify selling certainty that the evidence has not earned.
Here is the damaging admission without the pivot buried three paragraphs later:
A broad panel can contain information a narrower workup misses. The person interpreting it may be unusually skilled. You may feel deeply validated by seeing your experience represented on a page. We cannot prove that will not happen.
The reason our verdict stays “usually not the best first $499” is not that the report contains nothing. It is that the clinical-use evidence is thinner than the measurement evidence, while the downstream cost and interpretation dependency are real.
The limitations we would want disclosed on any sales page
- The pivotal method studies are small and company-funded. They support the measurements studied; they are not independent outcomes trials.
- One collection day is still one collection day. Perimenopausal hormones fluctuate. Cycle Mapping adds longitudinal collection, but it also adds cost and burden.
- Route matters. Oral, sublingual, and transdermal hormone exposure cannot be treated as interchangeable.
- Hydration and timing rules matter. The kit has fluid and timing instructions for a reason.
- Laboratory ranges do not create a diagnosis. A result can be outside a range without explaining your symptoms, or inside a range while you remain symptomatic.
- More markers create more interpretation choices. That can produce insight. It can also produce a supplement list without resolving the medical question.
- The evidence base is stronger for analytical agreement than patient outcomes. That is the central distinction, not a footnote.
- We did not personally test the kit. We cannot report firsthand checkout, packaging, collection comfort, privacy, support, or report-release experience.
The other things people actually run into
- Missing the timing window and needing a redraw.
- Starting collection on the wrong cycle day.
- Learning too late that a current clinician will not use the result.
- Paying a separate interpretation fee.
- Being offered supplements rather than a medical plan.
- International customs and return-shipping costs.
- Buying the flagship because it feels safer than choosing a narrow test.
- Receiving a large report and still not knowing what to do Monday morning.
The test may give you more data. It cannot guarantee more direction.
14. If not DUTCH, where can $499 go further?
The cleanest comparison is not DUTCH versus “doing nothing.” It is DUTCH versus a clinician-led path. At current published prices, $499 is more than Midi’s $250 self-pay first visit plus its $150 follow-up, and it is more than eight months at Sesame’s advertised starting price of $59 per month. Medication costs can still be separate.
That comparison is deliberately narrow. It uses provider-published prices instead of unstable pharmacy coupons or made-up annual treatment totals.
What $499 buys on three current paths
| Path | Current published price | What $499 covers before medication | The catch |
|---|---|---|---|
| DUTCH Complete direct | $499 once | Kit, laboratory processing, report, manufacturer education | Independent clinical interpretation and follow-up are not included |
| Midi self-pay | $250 first visit + $150 follow-up | One 30-minute first visit and one 15-minute return visit, with $99 left | Labs, prescriptions, and other services may cost extra; insurance and eligibility vary |
| Sesame menopause subscription | From $59/month | At the advertised $59 tier, eight months cost $472; includes provider access and basic lab work when the provider orders it | Higher-priced arrangements may cost more; medication is separate; lab-payment exceptions apply in NY, NJ, RI, and ND |
The point is not that every reader should choose Midi or Sesame. The point is that the $499 alternative is not ignorance. It can be a clinician, a plan, a follow-up, and time to adjust.
For broader comparisons, see the best online HRT providers for menopause and what online HRT costs in 2026.
Midi: the strongest fit when insurance or FDA-approved prescribing matters
Midi’s current page lists self-pay prices of $250 for a 30-minute first visit and $150 for a 15-minute follow-up. It says it is in network with most PPO plans nationwide, while coverage, copays, deductibles, and coinsurance depend on the specific plan.
Midi also states:
- Medicare is out of network; Medicare beneficiaries may use self-pay but cannot submit Midi-related claims.
- Medicaid and Medi-Cal patients are not accepted at this time.
- HSA/FSA payment is available for visits and services.
- Prescription and laboratory costs may be additional.
For a woman whose priority is a clinician-led menopause decision and access to FDA-approved prescription options when appropriate, that is a more direct first purchase than a report.
Check Midi coverage — sponsored affiliate link
Sesame: the strongest cash-pay subscription comparison
Sesame’s current menopause page advertises care from $59 per month. It includes provider selection, video visits as needed, unlimited messaging, same-day prescriptions when appropriate, and basic laboratory work when the provider orders it. Medication is not included in the subscription price.
The included-lab list currently names a complete blood count, hemoglobin A1c, thyroid testing, a lipid panel, and a comprehensive metabolic panel. State payment exceptions apply, and Sesame says providers on its platform cannot prescribe controlled substances online.
Check Sesame menopause care — sponsored affiliate link
So which one is you?
Choose the test path when a clinician has already named the question, accepts the method, and will act on the result.
Choose the clinician-first path when your actual goal is diagnosis, treatment, medication selection, risk review, or follow-up.
Use the matching path when you are not sure whether online care is appropriate, need to compare insurance and cash-pay routes, or want a safety flag before choosing a provider.
Use Find My HRT Path — about 90 seconds, no provider purchase required.
15. What tests do you actually need before starting HRT?
Many women over 45 with typical perimenopause symptoms do not need a hormone panel before a treatment discussion. Testing becomes useful when it answers a different question: pregnancy, anemia or iron deficiency, thyroid disease, diabetes risk, abnormal bleeding, premature ovarian insufficiency, or another condition suggested by the history.
The answer is not “buy a cheaper hormone panel.” It is “test the question that could change the next step.”
The targeted-test decision table
| Clinical question | Test or evaluation a clinician may consider | Why it can change the next step | What it does not do |
|---|---|---|---|
| Could pregnancy explain missed periods or change treatment safety? | Pregnancy test | Changes diagnosis, medication choices, and urgency | Diagnose perimenopause |
| Could heavy or prolonged bleeding have caused anemia or iron deficiency? | CBC; ferritin or iron studies when indicated | Can identify anemia or depleted iron and trigger treatment or bleeding evaluation | Prove that every fatigue symptom is caused by iron deficiency |
| Could thyroid disease be contributing to cycle, temperature, mood, heart-rate, or energy changes? | TSH, with follow-up thyroid testing when indicated | Can identify a treatable differential diagnosis | Determine whether you “need estrogen” |
| Is there a metabolic or cardiovascular risk factor relevant to the treatment discussion? | Blood pressure, lipids, glucose or HbA1c based on age and risk | Informs long-term risk assessment and the broader care plan | Usually explain symptoms by itself; lipid and glucose abnormalities can be silent |
| Is menopause suspected before age 45? | Targeted FSH testing in the situations defined by current guidance | Can support evaluation of early menopause or premature ovarian insufficiency | Turn one fluctuating result into a diagnosis in every younger patient |
| Is there postmenopausal bleeding, very heavy bleeding, bleeding between periods, or another concerning pattern? | Clinical examination and appropriate imaging, sampling, or referral—not a DUTCH panel | Evaluates causes that urine hormone metabolites cannot rule out | Safely replace an in-person workup |
| Is an endocrine disorder such as Cushing syndrome or adrenal insufficiency genuinely suspected? | Guideline-recommended endocrine testing selected by a clinician | Uses validated diagnostic pathways for the suspected disorder | Let an abnormal DUTCH cortisol graph stand alone as a diagnosis |
This is not a universal shopping list. A clinician should choose tests from your symptoms, age, cycle pattern, medications, pregnancy possibility, bleeding history, and risk factors.
When FSH matters—and when it does not
The clean age split is:
- Age 45 or older with typical symptoms: current NICE guidance says identify perimenopause or menopause without laboratory tests in otherwise healthy people.
- Age 40–45 with symptoms and cycle change: FSH can be considered.
- Under 40 with suspected menopause: evaluate for premature ovarian insufficiency. The current international POI guideline uses at least four months of disordered cycles plus an FSH concentration above 25 IU/L; repeat FSH after 4–6 weeks when the diagnosis remains uncertain. NICE still uses two elevated samples in its pathway.
That is a defined medical use. It is not the same as buying 35 urinary markers because a single blood result felt incomplete.
What to say at your appointment
Use the perimenopause symptoms checklist to bring a dated symptom and cycle timeline, then use this instead of asking someone to “check all my hormones”:
“My symptoms are affecting my daily life. Based on my age, cycle changes, bleeding pattern, medications, and risks, what diagnoses are you considering? Which tests would change your decision, and which would only add numbers? If typical perimenopause is the leading explanation, can we discuss treatment options now?”
That is not a timid request. It is a clinical question with a decision attached.
You were never wrong to want a workup. You may simply have been sold the wrong workup.
16. What should you ask before spending $499 on DUTCH?
Ask these seven questions before the collection strip leaves the box. If the seller or clinician cannot answer them clearly, the test is not ready for you—no matter how impressive the sample report looks.
- What exact clinical question is this panel meant to answer for me? “Hormone imbalance” is not specific enough.
- What changes if the result is high, low, normal, or ambiguous? Make the decision tree visible before the number exists.
- Why can a clinical assessment or a targeted standard test not answer the same question? The broadest panel should not be the default merely because it contains more columns.
- Does my medication route make urinary interpretation appropriate? Ask this explicitly if you use oral or sublingual hormones.
- Who will interpret the report, what are their credentials, and what will that cost? “A provider can interpret it” is not the same as having one booked.
- Are you using the result to prescribe medication, recommend supplements, or both? Know what purchase the test is feeding.
- What happens if the panel does not explain my symptoms? A good plan includes the exit route.
The DUTCH Test Decision Checker
Use this simple rule:
- No named clinician: do not buy yet.
- No exact question: do not buy yet.
- No stated action under each result: do not buy yet.
- Oral or sublingual hormone route not addressed: do not buy yet.
- A safety symptom is being delayed by mail-order testing: use in-person care first.
- All five are resolved: the purchase may be rational, even if it is not the choice we would make for routine menopause diagnosis.
Run Find My HRT Path before you pay — it takes about 90 seconds and will tell you when online care is not the right starting point.
17. Where does Winona fit in this DUTCH test review?
Winona is an affiliate partner, but it is not the lead recommendation on this page. It serves a narrower age range and sells both FDA-approved prescription products and non-FDA-approved compounded products. Those categories must stay separate.
We may earn a commission if you use a sponsored Winona link. That does not change the DUTCH verdict, and it does not make Winona the default alternative.
Winona’s current FAQ says most women ages 35–59 with menopause symptoms are generally eligible, subject to physician review. It lists:
- FDA-approved products: estrogen tablets, progesterone capsules, and estrogen patches.
- Compounded products: creams made by Winona’s 503A compounding pharmacies. These products are not FDA-approved.
- Testosterone: Winona says it does not prescribe testosterone. Testosterone is a Schedule III controlled substance in the United States and requires a prescription.
Do not blur those lines. A compounded cream is not FDA-approved because some ingredients may also appear in approved products. FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.
Winona can fit a woman aged 35–59 who understands the cash-pay model, wants its specific care format, and is comfortable choosing between clearly labelled FDA-approved and compounded options with a prescriber. It is not our lead route for a reader whose main problem is whether to spend $499 on diagnostic testing.
See Winona eligibility — sponsored affiliate link
Provider source: Winona FAQ, checked September 3, 2026. Regulatory source: FDA on compounded drugs.
18. What did The HRT Index actually verify?
We checked every direct panel price, product scope, state-restriction notice, return term, insurance and HSA/FSA statement, current CLIA certificate, public CAP artifact, patient pathway, sample report, collection instructions, cited method paper, medical guideline, provider comparison, and public Trustpilot review used on this page.
Verified directly on September 3, 2026
- All eight prices on Precision Analytical’s store.
- The listed panel contents and collection formats.
- The New York, Maryland, and Rhode Island restriction notice.
- The one-year return window, returned-kit requirement, non-refundable shipping, $25 restocking fee, and up-to-30-day card refund timeline.
- The FAQ statements on direct purchase, required provider interpretation, insurance, out-of-network reimbursement, and HSA/FSA card acceptance.
- The provider-led steps on dutchtest.com/patients.
- The current CLIA Certificate of Compliance and its dates.
- The CAP language on the licensing page and the 2018 document linked as public support.
- The current sample-report length.
- The 2019 and 2021 method papers, including sample sizes, endpoints, funding, author affiliations, and route limitation.
- The current FDA LDT page and post-vacatur regulatory text.
- The Menopause Society, ACOG, and NICE guidance used here.
- The Trustpilot profile, score, review count, status, and five public reviews.
- Midi’s current self-pay and insurance page.
- Sesame’s current menopause subscription page, included-lab list, state exceptions, and medication-cost disclosure.
- Winona’s current eligibility, product-category, and testosterone statements.
- The live internal destinations linked from this page, including Find My HRT Path and the contextual HRT guides.
What remains unverified or cannot be universalized
- We did not buy a kit, submit a sample, or test the full checkout, collection, privacy, or support experience as a patient.
- Current CAP accreditation was not established by the public artifact we found.
- The exact statutory or operational rule behind each state restriction was not explained on the checked product pages.
- Practitioner interpretation fees vary and are not published as one DUTCH-wide price.
- A particular health plan’s reimbursement decision cannot be predicted from another plan’s policy.
- International duties, customs, shipping, and local clinical use vary by destination.
- A personal DUTCH result cannot be interpreted from this page.
Provider-stated versus independently established
| Claim type | How it is labelled here |
|---|---|
| Direct price, return policy, collection format, state notice | Manufacturer-stated and date-verified |
| CLIA certificate | Verified from the current certificate |
| CAP accreditation | Not established by the public evidence found |
| Analytical method agreement | Supported by cited peer-reviewed studies, with funding and affiliations disclosed |
| Menopause diagnosis or outcome improvement | Not established by the cited DUTCH method papers |
| Insurance reimbursement | Possible only; plan-specific and not guaranteed |
| Provider price and inclusions | Provider-stated and date-verified |
| Trustpilot experience | Individual consumer report; not medical evidence |
This page was produced under The HRT Index Verification Standard. We do not issue invented numeric product scores. We evaluate evidence and care paths on five pillars, in this order: clinical legitimacy, care quality, medication fit, price transparency, access.
Found something that changed? Email partners@thehrtindex.com. We will check the primary source and update the verification date.
DUTCH test FAQ
How much does the DUTCH test cost?
Precision Analytical’s direct prices, verified September 3, 2026, are: DUTCH Complete $499; DUTCH Plus $650; Cycle Mapping $550; Cycle Mapping + Complete $650; Cycle Mapping Plus $700; DUTCH Adrenal $399; DUTCH Sex Hormone Metabolites $399; and the Cortisol Awakening Response $299. A reseller may charge a different amount or bundle another service.
Is the DUTCH test covered by insurance?
Precision Analytical does not bill or accept insurance and considers itself out of network. When a provider orders the test and your plan includes out-of-network benefits, the company says you may submit a receipt for possible reimbursement. Payment is not guaranteed. Aetna’s published menopause-hormone policy cited on this page is for salivary testing and should not be misrepresented as a universal urine-panel denial.
Can I use an HSA or FSA to pay for DUTCH?
Precision Analytical says it accepts HSA and FSA payment when the account has a payment card. Merchant acceptance does not decide whether your plan or current tax rules treat the expense as qualified. Confirm eligibility with the account administrator before relying on reimbursement or a tax benefit.
Is the DUTCH test FDA approved?
No. DUTCH has not received FDA clearance or approval. It is offered as a laboratory-developed testing service. The FDA’s 2024 LDT rule was vacated in March 2025, and FDA reverted the affected regulatory text in September 2025. Precision Analytical’s CLIA certification is a separate laboratory credential; it is not FDA approval or proof of clinical utility.
Can I order the DUTCH test without a doctor?
Precision Analytical’s FAQ says anyone can purchase a test, but it also says a healthcare provider is needed to interpret the report and build a treatment plan. Product pages say restrictions apply in New York, Maryland, and Rhode Island and direct residents to call. Direct purchase does not include an independent clinical interpretation.
How long do DUTCH test results take?
Precision Analytical reports an average laboratory turnaround of about 6–7 days after the specimen reaches the lab. Total time also includes kit delivery, collection timing, return shipping, report release, and the wait for a clinical discussion.
Is the DUTCH test accurate?
Published method studies support dried-versus-liquid agreement and four-spot-versus-24-hour agreement for many selected analytes under the studied conditions. That supports parts of the collection and measurement method. It does not prove that DUTCH Complete diagnoses perimenopause, selects a universally correct HRT dose, or improves patient outcomes.
Will my doctor use DUTCH test results?
Do not guess. Ask before buying. Mainstream menopause guidance does not rely on broad urinary hormone panels for routine diagnosis or routine compounded-hormone dose-setting, so a clinician may decline to use the report. The test has practical value only when the person responsible for your care has agreed to interpret it and can name the decision it will change.
Can I take the DUTCH test while I am on HRT?
Medication route matters. The 2019 DUTCH method paper says oral and sublingual routes undergo first-pass metabolism and that urine evaluation may not be appropriate, while route-specific studies support selected measurements after transdermal estradiol. Ask the ordering clinician how your exact product, route, dose, and timing affect interpretation. Do not change a prescription from this page or from a self-read report.
Do I need a hormone test before starting HRT?
Usually not when you are 45 or older with typical perimenopause or menopause symptoms. Your history, symptoms, cycle pattern, uterus status, and risks often guide the first discussion. Targeted testing may be appropriate when you are younger, pregnancy is possible, bleeding is abnormal, or another diagnosis is suspected.
What should I avoid before taking a DUTCH test?
Follow the instructions in your own kit. Current DUTCH Complete instructions include precise collection times, no fluids for two hours before samples, a collection-day fluid limit, and rules involving food, exercise, sleep, supplements, and hormones. Ask the ordering clinician which medications or supplements to continue; do not stop a prescription because of a review page.
Can I get a refund on a DUTCH test?
The current product pages state that a kit may be returned within one year of purchase, the kit must be returned before the refund is issued, shipping is non-refundable, a $25 restocking fee applies, and credit-card refunds can take up to 30 days. The published policy does not promise a refund after laboratory processing, so confirm your status before collection.
Still deciding between a test and actual menopause care?
Take The HRT Index’s Find My HRT Path tool to get a best-fit route, two backups, and a clear “when online care is not the right starting point” flag. It takes about 90 seconds.
Sources
Precision Analytical and commercial terms
- DUTCH Complete product page
- DUTCH Complete 2025 collection instructions
- DUTCH Complete sample report currently linked from the store page
- DUTCH report enhancements: four standard samples and optional fifth mid-sleep sample
- Precision Analytical about page: company history and manufacturer-reported 6–7 day average turnaround
- DUTCH Plus product page
- DUTCH Cycle Mapping product page
- DUTCH Cycle Mapping + Complete bundle
- DUTCH Cycle Mapping Plus
- DUTCH Adrenal
- DUTCH Sex Hormone Metabolites
- Cortisol Awakening Response
- DUTCH patient pathway
- DUTCH FAQ
- Precision Analytical licensing page
- Current CLIA Certificate of Compliance
- 2018 CAP Surveys participation certificate
- Independent reseller checked for price comparison
Peer-reviewed evidence
- Newman M, Pratt SM, Curran DA, Stanczyk FZ. Evaluating urinary estrogen and progesterone metabolites using dried filter paper samples and GC–MS/MS. BMC Chemistry. 2019;13:20.
- Newman M, Curran DA. Reliability of a dried urine test for comprehensive assessment of urine hormones and metabolites. BMC Chemistry. 2021;15:18.
- Newman MS, Curran DA, Mayfield BP, Saltiel D, Stanczyk FZ. Transdermal estradiol gel study. Steroids. 2022;184:109038.
- Newman MS, Mayfield BP, Saltiel D, Stanczyk FZ. Transdermal estradiol patch study. Steroids. 2023;189:109149.
Menopause guidance and regulation
- ACOG: Do I need hormone testing during perimenopause?
- ACOG Clinical Consensus No. 6: Compounded Bioidentical Menopausal Hormone Therapy
- The Menopause Society 2022 Hormone Therapy Position Statement
- NICE guideline NG23: Menopause—identification and management
- ASRM/ESHRE/IMS evidence-based guideline: Premature Ovarian Insufficiency
- FDA: Laboratory Developed Tests
- CMS: Clinical Laboratory Improvement Amendments
- FDA: Compounding and FDA—Questions and Answers
- DEA: Drug Scheduling
- Endocrine Society: Diagnosis of Cushing’s Syndrome
Insurance, provider comparisons, and reviews
- Aetna Clinical Policy Bulletin 0608: Salivary Tests
- Midi pricing and insurance
- Sesame menopause treatment
- Winona FAQ
- Trustpilot profile for dutchtest.com
Source policy: Commercial terms above were checked September 3, 2026. Manufacturer marketing is labelled as manufacturer-stated. Individual reviews are treated as experience reports, not efficacy evidence. Method papers are kept within their endpoints, with funding and affiliations disclosed.
Compounded medications are not FDA-approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. FDA-approved and compounded options are labelled separately throughout this page and are not presented as equivalent.
